Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group
- PMID: 4884063
- DOI: 10.1002/1097-0142(196901)23:1<109::aid-cncr2820230112>3.0.co;2-1